Catalyst Wire Dossier Catalyst Wire Dossier

Tuberculin (2 TU)

tuberculin · Statens Serum Institut
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tuberculin (2 TU), covering 2015-04-17 to 2015-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses [Phase 2, Phase 3]

See pricing